Correlation Between GlaxoSmithKline PLC and Rbb Fund

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Rbb Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Rbb Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Rbb Fund , you can compare the effects of market volatilities on GlaxoSmithKline PLC and Rbb Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Rbb Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Rbb Fund.

Diversification Opportunities for GlaxoSmithKline PLC and Rbb Fund

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Rbb is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Rbb Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rbb Fund and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Rbb Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rbb Fund has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Rbb Fund go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Rbb Fund

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 6.92 times less return on investment than Rbb Fund. In addition to that, GlaxoSmithKline PLC is 1.5 times more volatile than Rbb Fund . It trades about 0.01 of its total potential returns per unit of risk. Rbb Fund is currently generating about 0.12 per unit of volatility. If you would invest  2,525  in Rbb Fund on August 30, 2024 and sell it today you would earn a total of  1,244  from holding Rbb Fund or generate 49.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy84.68%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Rbb Fund

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Rbb Fund 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Rbb Fund are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak essential indicators, Rbb Fund may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Rbb Fund Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Rbb Fund

The main advantage of trading using opposite GlaxoSmithKline PLC and Rbb Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Rbb Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rbb Fund will offset losses from the drop in Rbb Fund's long position.
The idea behind GlaxoSmithKline PLC ADR and Rbb Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets